Cardiology

Newly identified genetic errors may prevent heart attacks

To reduce risk of heart attack, the benefits of a healthy lifestyle are clear. But genetics can still stack the deck. Some people's genes bestow a natural advantage—or disadvantage—in protecting against heart disease, ...

Medications

Evolocumab: No hint of added benefit

Evolocumab (trade name: Repatha) has been approved since July 2015 for two therapeutic indications: on the one hand, for hypercholesterolaemia or mixed dyslipidaemia, and on the other, for homozygous familial hypercholesterolaemia. ...

Medical research

Potential way to control cholesterol levels via dying cells

A discovery about how the body deals with the cholesterol contained within its dying cells has suggested an exciting new approach to control people's cholesterol levels – and thus their risk of developing heart disease.

page 27 from 38